Literature DB >> 16010485

Autopsy diagnosis of 21-hydroxylase deficiency CAH in a case of apparent SIDS.

Tiziana G Gozzi1, Naomi P Harris, Ivan N McGown, David M Cowley, Andrew M Cotterill, Peter E Campbell, P Kym Anderson, Garry L Warne.   

Abstract

A 5-month-old boy with no history of vomiting, early sexual development, or noticeable significant illness was found dead in bed. Autopsy demonstrated bilateral adrenal hyperplasia unequivocally shown on biochemical testing of blood and urine to be due to 21-hydroxylase deficiency. Genetic analysis of the CYP21 gene showed compound heterozygosity; 1 allele contained a pseudogene sequence (gene conversion) and the other contained a previously described I172N point mutation. On theoretical grounds, the genotype would have been expected to cause simple virilizing congenital adrenal hyperplasia but, because no other cause of death could be found, it is possible that it caused a fatally severe loss of enzyme activity in this child. If this assumption is valid, newborn screening would have prevented this death, had it been available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010485     DOI: 10.1007/s10024-005-0004-0

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  3 in total

1.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

2.  Investigation of unexplained infant deaths in Jerusalem, Israel 1996-2003.

Authors:  Eli M Eisenstein; Ziona Haklai; Shepard Schwartz; Aharon Klar; Nechama Stein; Eitan Kerem
Journal:  Arch Dis Child       Date:  2006-10-30       Impact factor: 3.791

3.  The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimester.

Authors:  Zoe C Johnston; Michelle Bellingham; Panagiotis Filis; Ugo Soffientini; Denise Hough; Siladitya Bhattacharya; Marc Simard; Geoffrey L Hammond; Peter King; Peter J O'Shaughnessy; Paul A Fowler
Journal:  BMC Med       Date:  2018-02-12       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.